ArticleCureus2025
Complementary Medicine Linked to a Significant Prostate-Specific Antigen (PSA) Reduction in a 61-Year-Old Man: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical treatment for metastatic prostate cancer (mPC) involves androgen deprivation therapy (ADT) and selective use of surgery, chemotherapy, and/or radiation therapy. Our 61-year-old Chinese man with mPC had a prostate-specific antigen (PSA) drop of over 100 ng/mL with herbal medicine. Presenting atypically with a supraclavicular mass and an initial PSA greater than 20 times the upper normal limit, he self-medicated with herbs while pending insurance approval of prescribed ADT. After two months, his PSA dropped 10-fold. Subsequent chemotherapy dropped his PSA to within the normal range. This highlights the potential of traditional herbal medicine to benefit patients and provide complementary therapy to established drug regimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.